(Q36387571)

13 August 2017

1 reference

title

The immunological consequences of injury (English)

1 reference

acute inflammatory response to non-antigenic stimulus

13 August 2017

1 reference

Gene Ontology release 2020-05-02

1 reference

Ni Choileain N

1

1 reference

PubMed ID

16459497

13 August 2017

Redmond HP

series ordinal

2

1 reference

13 August 2017

1 February 2006

1 reference

Journal of the Royal College of Surgeons of Edinburgh

13 August 2017

1 reference

13 August 2017

4

1 reference

13 August 2017

1

1 reference

13 August 2017

23-31

1 reference

Postinjury multiple organ failure: a bimodal phenomenon

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Prolonged survival of human skin allografts following thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

The effects of injury on the adaptive immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Update on the mechanisms of immune suppression of injury and immune modulation

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Severe injury triggers antigen-specific T-helper cell dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Clinical review: immunodepression in the surgical patient and increased susceptibility to infection

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Immune deficiency following thermal trauma is associated with apoptotic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Multiple organ failure in patients with thermal injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle?

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Current treatment of severely burned patients

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Experience with polymicrobial sepsis in a regional burn unit

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Differential expression of transforming growth factor-beta receptors in a rabbit zone II flexor tendon wound healing model

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Multiple organ failure. Pathophysiology and potential future therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Macrophage elimination increases bacterial translocation and gut-origin septicemia but attenuates symptoms and mortality rate in a model of systemic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Mechanism of enhanced susceptibility to sepsis following hemorrhage. Interleukin-10 suppression of T-cell response is mediated by eicosanoid-induced interleukin-4 release.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Dominance of T-helper 2-type cytokines after severe injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Etiology of multiple organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Thermal injury alters macrophage responses to prostaglandin E2: contribution to the enhancement of inducible nitric oxide synthase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Mechanisms of altered monocyte prostaglandin E2 production in severely injured patients

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Burn-induced nitric oxide release in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Thermal injury-induced immunosuppression in mice: the role of macrophage-derived reactive nitrogen intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

The roles of macrophage (M phi) and PGE-2 in postburn immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Modulation of macrophage hyperactivity improves survival in a burn-sepsis model

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Alterations of acute phase reaction and cytokine production in patients following severe burn injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Tumor necrosis factor and immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Cachectin/TNF production in experimental burns and Pseudomonas infection

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Plasma cytokines after thermal injury and their relationship to infection

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Plasma cytokine levels in patients with severe burn injury--with reference to the relationship between infection and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Concentrations of cytokines in plasma of patients with large burns: their relation to time after injury, burn size, inflammatory variables, infection, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Acute ethanol exposure prior to thermal injury results in decreased T-cell responses mediated in part by increased production of IL-6

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Regulation of immune responses by TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Serum TGF-beta in thermally injured rats

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Transforming growth factor-beta impairs postburn immunoglobulin production by limiting B-cell proliferation, but not cellular synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Transforming growth factor-beta1 and splenocyte apoptotic cell death after burn injuries

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

The 1997 Moyer Award. Cytokine production in patients with hypertrophic burn scars.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

A study of cytokines in burn blister fluid related to wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Nitric oxide--a new endogenous immunomodulator.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Regulation of lymphocyte functions by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Kinetics of nitrogen oxide production following experimental thermal injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Nitric oxide production is intensely and persistently increased in tissue by thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Nitric oxide and macrophage function

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Prostaglandin E2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Effect of PGE2 and of agents that raise cAMP levels on macrophage activation induced by IFN-gamma and TNF-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Changes in gut mucosal nitric oxide synthase (NOS) activity after thermal injury and its relation with barrier failure

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Prostaglandins and the Inflammatory Response

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Clinical significance of the alterations of plasma prostaglandin E2 (PGE2) in severely burned patients

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Human cyclooxygenase-2 cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

The role of prostaglandin E2 in immune suppression following injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Cyclooxygenase 2-mediated suppression of macrophage interleukin-12 production after thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Differential Regulation of Cyclo-Oxygenase-1 and Cyclo-Oxygenase-2 Gene Expression by Lipopolysaccharide Treatmentin vivoin the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Insights into the role of gammadelta T lymphocytes in the immunopathogenic response to thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Cyclooxygenase-2 inhibitor NS-398 improves survival and restores leukocyte counts in burn infection

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Blocking prostaglandin E2 after trauma attenuates pro-inflammatory cytokines and improves survival

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

An imbalance in T-helper cell subsets alters immune response after cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Abnormalities of antibody production after thermal injury. An association with reduced interleukin 2 production

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Antibody formation after murine injury

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Association of sepsis with an immunosuppressive polypeptide in the serum of burn patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Anergy, immunosuppressive serum, and impaired lymphocyte blastogenesis in burn patients

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Impairment of specific host defense mechanisms in patients with chronic post-traumatic osteomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Interleukin-12 and its role in the generation of TH1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

A relationship between the generation of burn-associated type 2 T cells and their antagonistic cells in thermally injured mice

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Determination of the immunoglobulin E postoperative variation as a measure of surgical injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

The Th2 response as monitored by CRTH2 or CCR3 expression is severely decreased during septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Injury, sepsis, and the regulation of Toll-like receptor responses

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Interleukin-10 Is Associated with the Development of Sepsis in Trauma Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

CD4+CD25+ regulatory T cells control innate immune reactivity after injury

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Glucocorticoids and muscle catabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

Natural adjuvants: endogenous activators of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1479-666X%2806%2980018-1

7 January 2021

10.1016/S1479-666X(06)80018-1

Identifiers

DOI

0 references

PubMed ID

16459497

1 reference

PubMed ID

16459497